Clinical Report: Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

Overview

Raman spectroscopy is being recognized as a promising diagnostic tool for rapid detection of pandemic-prone viruses. Despite significant advances, challenges in clinical translation, such as regulatory hurdles and technical limitations, and research gaps for high-risk pathogens remain.

Background

Raman spectroscopy offers a non-destructive method for molecular fingerprinting of biological samples, which is crucial in virology for rapid diagnostics. The COVID-19 pandemic highlighted the need for innovative diagnostic tools to manage infectious diseases effectively. However, while Raman techniques show potential, there is a disparity in research focus on high-impact viruses like SARS-CoV-2 compared to high-risk pathogens such as Lassa or Marburg, which remain underexplored.

Data Highlights

Raman-based methods have shown rapid detection capabilities, including:
- Influenza detection in minutes, supported by recent studies
- High accuracy in SARS-CoV-2 identification from saliva and swabs, with specific accuracy rates
- Multiplexed detection of viruses in complex samples, as demonstrated in clinical trials

Key Findings

• Raman spectroscopy provides label-free molecular fingerprinting of viruses.
• Enhanced techniques like SERS, TERS, and CARS improve sensitivity and resolution, as evidenced by recent research.
• Research is concentrated on accessible viruses, leaving high-risk pathogens underexplored.
• Technical barriers include weak signal intensity and fluorescence interference, which need addressing.
• Regulatory and integration challenges hinder clinical translation of Raman diagnostics, necessitating focused efforts to overcome these issues.

Clinical Implications

Healthcare professionals should consider the potential of Raman spectroscopy for rapid viral diagnostics while being aware of its current limitations, such as sensitivity and regulatory challenges. Addressing these technical and regulatory challenges will be essential for broader clinical adoption.

Conclusion

Raman spectroscopy represents a significant advancement in virology diagnostics, yet further research and development are necessary to overcome existing barriers, such as technical limitations and regulatory hurdles, to fully realize its potential in clinical settings.

References

1. Infection, 2023 -- Pioneering Advances in Tuberculosis Diagnostic Techniques
2. the analytical scientist, 2026 -- Spectroscopy Roundup: Rover Dogs and Raman Vision
3. The Journal of Infectious Diseases, 2023 -- From Epidemics to Pandemics: Over a Decade of Strengthening SARInet Laboratory Surveillance and Response for Respiratory Viruses in the Americas
4. Infection, 2025 -- Assessment of a connected device for isothermal molecular diagnostics
5. Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings | Infection Control | CDC
6. Chemometric Methods Applied to Infrared and Raman Spectroscopy for Arboviruses Diagnosis: A Systematic Review With Meta-Analysis - PubMed
7. Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings | Infection Control | CDC
8. Chemometric Methods Applied to Infrared and Raman Spectroscopy for Arboviruses Diagnosis: A Systematic Review With Meta-Analysis - PubMed